🇨🇾 Country Profile

Cyprus

Fast-growing pharmaceutical trade with Cyprus

🇨🇾 $5.0M

Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Eurostat records what Cyprus imports from India. DGCIS records what India exports to Cyprus. Category and product detail from DGCIS.

$5.0M

Scale

India supplies $5.0M in pharmaceutical products to Cyprus — affordable medicine reaching Europe.

68%

Medicine

Primarily medicine ingredients (68%), supplemented by medicines and surgical & hospital supplies.

5.0×

Trajectory

Rapid expansion: Cyprus' imports of Indian pharmaceutical products have grown 5.0× over the past decade, from $1.0M to $5.0M.

Context

Part of India's pharmaceutical supply network across Europe.

✦

Impact

A pharmaceutical relationship documented by both countries — verified trade data confirming the flow of affordable medicine.

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Medicine Ingredients $12.8M (68.4%) Medicines $5.6M (29.8%) Surgical & Hospital Supplies $0.33M (1.8%) Traditional & Herbal $0.02M (0.1%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $15.1M in active pharmaceutical ingredients and bulk drugs to Cyprus in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Cyprus: $288M across 36 filings (2011-2026).